LifeVantage Co. (NASDAQ:LFVN – Get Rating) was the target of a significant increase in short interest during the month of August. As of August 15th, there was short interest totalling 45,700 shares, an increase of 18.4% from the July 31st total of 38,600 shares. Based on an average daily volume of 31,700 shares, the days-to-cover ratio is presently 1.4 days. Approximately 0.4% of the company's shares are short sold.

Institutional Trading of LifeVantage

Several institutional investors and hedge funds have recently made changes to their positions in LFVN. Private Advisor Group LLC purchased a new position in shares of LifeVantage during the second quarter valued at $49,000. Campbell & CO Investment Adviser LLC purchased a new position in shares of LifeVantage during the fourth quarter valued at $63,000. Victory Capital Management Inc. increased its stake in shares of LifeVantage by 30.4% during the first quarter. Victory Capital Management Inc. now owns 13,868 shares of the company's stock valued at $66,000 after buying an additional 3,235 shares during the period. O Shaughnessy Asset Management LLC increased its stake in shares of LifeVantage by 61.8% during the second quarter. O Shaughnessy Asset Management LLC now owns 24,368 shares of the company's stock valued at $106,000 after buying an additional 9,312 shares during the period. Finally, American Century Companies Inc. increased its stake in shares of LifeVantage by 30.3% during the first quarter. American Century Companies Inc. now owns 46,016 shares of the company's stock valued at $219,000 after buying an additional 10,706 shares during the period. 27.06% of the stock is currently owned by institutional investors.

LifeVantage Price Performance

Shares of NASDAQ:LFVN remained flat at $3.77 on Tuesday. The stock had a trading volume of 23,895 shares, compared to its average volume of 41,487. LifeVantage has a fifty-two week low of $3.71 and a fifty-two week high of $8.02. The company has a market capitalization of $47.32 million, a PE ratio of 15.79 and a beta of 1.21. The stock's 50 day simple moving average is $4.27 and its 200 day simple moving average is $4.51.

LifeVantage Announces Dividend

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on LifeVantage in a research report on Friday. They set a "buy" rating for the company.

LifeVantage Company Profile

(Get Rating)

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.

Further Reading

• Get a free copy of the StockNews.com research report on LifeVantage (LFVN)
• Shock Absorbers: 3 Low Volatility Dividend Stocks for Bumpy Times
• The Retail Sector: Winners And Losers From Q2 Earnings
• Can Targa Continue Rallying To Meet Its Price Target?
• Is Unity Software Ready To Rally After Rejecting AppLovin Offer?
• MarketBeat Podcast: The Time For Cloud Stocks May Be Now

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.